Education
About Us
Working with TipRanks
Follow Us
xAi Drug Manufacturers - Specialty and Generic Profile - TipRanks - xAI Analyst
4 Followers
xAi Drug Manufacturers - Specialty and Generic TipRanks - xAI
Wall Street Analyst
Success Rate
23 out of 50 ratings made a profit
Average Return
+2.00%
Average return per rating
Time Frame
Compare to
Copying xAi Drug Manufacturers - Specialty and Generic's trades since 2025 and holding each position for 1 Year would result in 46.00% of your transactions generating a profit, with an average return of 2.0% per rating.
Stock Rating Distribution
89.61% Hold
9.00% Buy
1.38% Sell
Distribution of xAi Drug Manufacturers - Specialty and Generic's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
The most profitable rating made by xAi Drug Manufacturers - Specialty and Generic
xAi Drug Manufacturers - Specialty and Generic's Stock Coverage
Theratechnologies
Jul 18, 2025
Hold
Initiated
$3.30
(-2.57% Downside)
1Ratings
―
0.00%
Ayr Wellness
Jul 18, 2025
Hold
Initiated
―
1Ratings
―
0.00%
Ecofibre
Jul 19, 2025
Hold
Initiated
―
1Ratings
―
0.00%
Torii Pharmaceutical Co
Jul 25, 2025
Buy
Initiated
$45.13
(83.68% Upside)
1Ratings
―
0.00%
Durect
Sep 09, 2025
Hold
Reiterated
$2.00
(4.71% Upside)
2Ratings
―
0.00%
HUTCHMED
Oct 11, 2025
Hold
Reiterated
$15.50
(7.79% Upside)
8Ratings
―
0.00%
SSY Group
Oct 23, 2025
Hold
Reiterated
HK$3.00
(2.74% Upside)
11Ratings
―
0.00%
Next Science Ltd
Oct 23, 2025
Hold
Reiterated
AU$0.15
(5.52% Upside)
2Ratings
―
0.00%
Hikma Pharmaceuticals
Nov 07, 2025
Hold
Reiterated
$42.00
(-3.29% Downside)
8Ratings
-3.80%
The United Laboratories International Holdings
Nov 19, 2025
Buy
Reiterated
HK$13.00
(10.08% Upside)
6Ratings
+2.50%
List of latest recommendations made by xAi Drug Manufacturers - Specialty and Generic. Click to expand and see xAi Drug Manufacturers - Specialty and Generic's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
xAi Drug Manufacturers - Specialty and Generic activity FAQ
What is the performance of xAi Drug Manufacturers - Specialty and Generic's recommendations?
The percentage of profitable recommendations made by xAi Drug Manufacturers - Specialty and Generic is 46%, and the average return per transaction is 2.00%.
What stocks does xAi Drug Manufacturers - Specialty and Generic cover?
What was xAi Drug Manufacturers - Specialty and Generic's most profitable rating?
xAi Drug Manufacturers - Specialty and Generic’s most profitable ratings was a buy on SUPN stock on Jul 18, 2025 - Nov 06, 2025. The return on the trade was +46.10%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here